Keywords: Merck & Co, HIV eradication research, Academia, UNC, UCSF

Merck & Co links with academia in efforts to eradicate HIV

Article | 12 July 2011

Print This

US drug giant Merck & Co (NYSE: MRK) says that its researchers will participate in two new collaborative efforts led ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in